Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | PNMT | P11086 | 2/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5085456 | 0.82 | IDO1 (0.37) | IDO1PNMTTAAR1CYP3A4SIGMAR1 | |
| SCHEMBL93982 | 0.78 | IDO1 (0.58) | IDO1PNMTTAAR1SIGMAR1 | |
| SCHEMBL840353 | 0.78 | — | — | |
| SCHEMBL20844684 | 0.77 | CSNK2A1 (0.46) | IDO1PNMTTAAR1 | |
| SCHEMBL2956766 | 0.77 | S1PR1 (0.41) | IDO1S1PR1PNMTTAAR1SIGMAR1 | |
| SCHEMBL5430585 | 0.77 | RECQL (0.42) | IDO1S1PR1PNMTTAAR1 | |
| SCHEMBL5158103 | 0.77 | CYP4F2 (0.42) | IDO1S1PR1PNMTTAAR1GPR84 | |
| SCHEMBL2735079 | 0.74 | TAAR1 (0.67) | PNMTTAAR1SIGMAR1 | |
| SCHEMBL3753927 | 0.73 | S1PR1 (0.38) | IDO1S1PR1PNMTTAAR1 | |
| SCHEMBL6104943 | 0.73 | THRB (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008033572-A1 | ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE | XENOPORT, INC. (US) | 2008-03-20 | — | — | WO | claimed |
| WO-2008033572-A1 | ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE | XENOPORT, INC. (US) | 2008-03-20 | — | — | WO | disclosed |